Categories NON REGULATORY Posted on

The subscription period in CS MEDICA A/S’s issue of units starts today

Today, August 17th, 2021, is the first day of the subscription period in CS MEDICA A/S’s (”CS MEDICA” or the ”Company”) issue of units prior to the planned listing on Spotlight Stock Market. The subscription period lasts until August 31st, 2021. A fully subscribed issue of units will initially provide CS MEDICA with approx. DKK 22.3 million and an additional approx. DKK 10.8 million at a later stage if all warrants of series TO 1 are exercised. Prior to the issue of units, CS MEDICA has received subscription commitments corresponding to approx. 60 percent of the initial issue volume. The prospectus and teaser of the Company and the offer are available on CS MEDICA’s (www.cs-medica.com), Sedermera Fondkommission’s (www.sedermera.se), Nordic Issuing’s (www.nordic-issuing.se) and Spotlight Stock Market’s (www.spotlightstockmarket.com) respective websites. Sedermera Fondkommission is the financial advisor and Markets & Corporate Law Nordic AB is the legal advisor in connection with the issue of units. Nordic Issuing is the issuing agent and Nordnet Bank AB is acting as Selling Agent.

Read More

For further information, please contact

Lone Henriksen, CEO
Tel: +45 7070 7337
E-mail: lh@cs-medica.com

About CS MEDICA

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product  manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stockmarked Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.

Advisors, selling agent, and issuing agency
Sedermera Fondkommission is the financial advisor, Phone: +46 (0) 40 615 14 10, info@sedermera.se. Markets & Corporate Law Nordic is the legal advisor to CS MEDICA in connection with the planned capitalization and listing. Nordic Issuing acts as issuing agency and Nordnet Bank AB is the selling agent.

Copyright © 2021 CS MEDICA . All rights reserved.

Our GDPR & Cookie Policy

Research - Company Valuation

Download CS Medica A/S new Research - Company Valuation

NEW